简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-01-05 15:53 SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
2026-01-05 15:51 Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
2026-01-04 13:28 Aster Guardians Global Nursing Award 2026 Worth $250,000 Extends Deadline Till 11th January 2026
2025-12-31 10:58 UAE’s Medcare Treats First International SMA Patient With Revolutionary Intrathecal Gene Therapy
2025-12-23 14:13 Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
2025-12-23 11:25 Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector
2025-12-22 16:02 Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
2025-12-22 10:36 Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale
2025-12-19 18:31 Pacific Prime Wins Silver for Best HR Management System from Human Resources Online in Hong Kong
2025-12-19 18:17 BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
2025-12-19 09:16 Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
2025-12-18 13:37 GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
2025-12-17 15:46 New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis
2025-12-16 18:54 Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
2025-12-16 13:44 Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
2025-12-12 18:07 Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
2025-12-11 14:43 Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
2025-12-11 14:07 Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
2025-12-11 14:02 Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
2025-12-11 13:43 Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator

Business Wire Weibo

Press Releases

Latest Releases